Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -104.10% is 23% below its 5-year average of -84.67%, near the low end of its 5-year range (-128.11%–-32.19%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.34% above its 12-month average of -116.11%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2026 (2026-06-30): -32.72%.
RETURN ON ASSETS (ROA)
-104.10%
RETURN ON ASSETS (ROA) AVG TTM
-116.11%
RETURN ON ASSETS (ROA) AVG 3Y
-102.15%
RETURN ON ASSETS (ROA) AVG 5Y
-84.67%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+10.34%
CURRENT VS 3Y AVG
-1.91%
CURRENT VS 5Y AVG
-22.95%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-29.61%
median of 616 covered companies
CURRENT VS SECTOR MEDIAN
-251.51%
vs the sector median at left
Intelligent Bio Solutions Inc.
Market Cap
$5.21M
Return on Assets (ROA)
-104.10%
TTM Avg
-116.11%
3Y Avg
-102.15%
5Y Avg
-84.67%
Market Cap
$5.20M
Return on Assets (ROA)
-367.93%
TTM Avg
-1046.51%
3Y Avg
-534.79%
5Y Avg
-427.52%
Market Cap
$5.17M
Return on Assets (ROA)
-1300.98%
TTM Avg
-1108.45%
3Y Avg
-604.75%
5Y Avg
-486.62%
Market Cap
$5.02M
Return on Assets (ROA)
-98.17%
TTM Avg
-154.79%
3Y Avg
-120.06%
5Y Avg
-94.26%
Market Cap
$5.32M
Return on Assets (ROA)
-106.49%
TTM Avg
-259.99%
3Y Avg
-586.63%
5Y Avg
-434.16%
Market Cap
$4.96M
Return on Assets (ROA)
-30.94%
TTM Avg
-24.01%
3Y Avg
-19.50%
5Y Avg
-23.56%
Market Cap
$5.01M
Return on Assets (ROA)
-71.72%
TTM Avg
-29.50%
3Y Avg
-8.92%
5Y Avg
-8.92%
Market Cap
$5.54M
Return on Assets (ROA)
-68.33%
TTM Avg
-234.58%
3Y Avg
-196.81%
5Y Avg
-171.01%
Market Cap
$4.83M
Return on Assets (ROA)
-28.02%
TTM Avg
-155.25%
3Y Avg
-160.56%
5Y Avg
-117.99%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intelligent Bio Solutions Inc. (INBS) | $5.21M | -104.10% | -116.11% | -102.15% | -84.67% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.20M | -367.93% | -1046.51% | -534.79% | -427.52% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.17M | -1300.98% | -1108.45% | -604.75% | -486.62% |
| Imunon, Inc. (IMNN)vs › | $5.02M | -98.17% | -154.79% | -120.06% | -94.26% |
| Alzamend Neuro Inc (ALZN)vs › | $5.32M | -106.49% | -259.99% | -586.63% | -434.16% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.96M | -30.94% | -24.01% | -19.50% | -23.56% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | -71.72% | -29.50% | -8.92% | -8.92% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.54M | -68.33% | -234.58% | -196.81% | -171.01% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.83M | -28.02% | -155.25% | -160.56% | -117.99% |
| enVVeno Medical Corporation (NVNO)vs › | $5.66M | -69.39% | -57.20% | -55.49% | -56.22% |
ROA
-104.1%
ROE
-225.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-06-30 | -104.10% |
| 2025-06-30 | -128.11% |
| 2024-06-30 | -73.71% |
| 2023-06-30 | -102.68% |
| 2022-06-30 | -67.24% |
| 2021-06-30 | -32.19% |
| 2020-06-30 | -127.80% |
| 2019-06-30 | -315.17% |
| 2018-06-30 | -201.13% |
| 2017-06-30 | -50.96% |
